📈 Net Income History (16 Quarters)
🧮 PBYI Net Income Breakdown
Understanding Net Income
Net income, also called the "bottom line" or net profit, is the money a company keeps after paying all expenses including cost of goods, operating costs, interest, and taxes. For PBYI, the trailing twelve month net income is $26.7M.
Why Net Income Matters
Net income is the ultimate measure of accounting profitability. It determines earnings per share (EPS), affects stock valuations through the P/E ratio, and represents the theoretical amount available to shareholders. However, net income can be influenced by accounting choices, which is why value investors often look at cash flow metrics alongside it.
PBYI's net income growth rate of 51.22% (based on log-linear regression of 16 quarters) indicates exceptional profit growth, often valued at premium multiples.
Net Income vs Cash Flow Metrics
Free Cash Flow: $53.6M →
Actual cash generated after capital expenditures. FCF often differs from net income due to depreciation, working capital changes, and capex timing.
Owner Earnings: $53.5M →
Buffett's preferred metric that adds back depreciation but subtracts maintenance capex. Often considered more accurate than net income.
EPS (Diluted): $0.52 →
Net income divided by diluted shares outstanding. The primary driver of the P/E ratio used in valuations.
Revenue: $231.2M →
The top line that net income is derived from. Net margin shows what percentage of revenue becomes profit.
P/E Ratio Analysis
PBYI's P/E ratio of 17.4x means investors pay $17.42 for every $1 of annual earnings. A P/E between 15-25 is average for the market, reflecting moderate growth expectations.
Net Margin: Profitability Efficiency
Net margin of 11.55% shows what percentage of PBYI's revenue converts to profit after all costs. Net margins between 10-20% are solid and typical of well-managed businesses.
Summary: PBYI Net Income Trend
PUMA BIOTECHNOLOGY, INC. (PBYI) has a net margin of 11.55%, which Zyberno classifies as good for a Healthcare company — above the 10% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 51.22% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses. For complete financial analysis, view the full PBYI stock report on Zyberno.
Frequently Asked Questions
What is PBYI's current net income?
PUMA BIOTECHNOLOGY, INC.'s TTM net income is $26.7M, growing at 51.22% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.
Is PBYI's net income growing?
PUMA BIOTECHNOLOGY, INC. (PBYI) has a net margin of 11.55%, which Zyberno classifies as good for a Healthcare company — above the 10% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 51.22% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.
What is PBYI's net profit margin?
PUMA BIOTECHNOLOGY, INC. (PBYI) has a net margin of 11.55%, which Zyberno classifies as good for a Healthcare company — above the 10% threshold Zyberno applies to healthcare businesses where R&D amortization, legal costs, and tax structures shape net margins. Net income grew at 51.22% annually — significantly above the 20% threshold Zyberno associates with high-growth businesses.
What is PBYI's P/E ratio?
PBYI's P/E ratio is 17.4x, meaning the market values the company at 17.4 times its annual earnings.
How does net income differ from free cash flow?
Net income is an accounting measure that includes non-cash items like depreciation, while free cash flow shows actual cash generated. PBYI's net income is $26.7M versus free cash flow of $53.6M. Large differences often indicate significant capital expenditures or working capital changes.
📊 Full PBYI Stock Report →
See PBYI's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.
💵 PBYI Free Cash Flow →
Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.
💰 PBYI Owner Earnings →
Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.
📈 PBYI Earnings Per Share →
Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.
🎯 PBYI Earnings Surprise (SUE) →
See whether PBYI is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.
📊 PBYI Revenue →
Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.
💰 PBYI Net Income →
Analyze the bottom-line profit, P/E ratio, and net profit margin trends.
🔶 PBYI Operating Income →
Analyze EBIT, operating margin, and core business profitability before interest and taxes.
💜 PBYI Gross Profit →
Analyze gross margin, pricing power, and profitability before operating expenses.